-
Hamacher Resource Group sponsors independent pharmacy workshop for HBW manufacturers
WAUKESHA, Wis. — Manufacturers of health, beauty and wellness products can learn how to grow their sales at a one-day workshop offered by Hamacher Resource Group, the company said Wednesday.
Hamacher announced that it would offer the workshop, How to Grow Sales Within Independent Pharmacy, at its Waukesha, Wis., headquarters on May 9, lead by VP and owners group member Dave Wendland.
-
FDA approves new allergy drug for children
MONMOUTH JUNCTION, N.J. — The Food and Drug Administration has approved a new drug for allergies in children made by Tris Pharma, the drug maker said Wednesday.
Tris announced the approval of Karbinal ER (carbinoxamine maleate) extended-release oral suspension in the 4 mg-per-five milliliter strength. The company said the drug was the first sustained-release histamine receptor blocking agent for seasonal and perennial allergic rhinitis in children 2 and older.